{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:48:05Z","timestamp":1775695685180,"version":"3.50.1"},"reference-count":131,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.jns.2011.01.002","type":"journal-article","created":{"date-parts":[[2011,2,7]],"date-time":"2011-02-07T04:11:06Z","timestamp":1297051866000},"page":"13-21","source":"Crossref","is-referenced-by-count":28,"title":["Neuromyelitis optica: An update"],"prefix":"10.1016","volume":"303","author":[{"given":"Sabrina","family":"Mat\u00e0","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Lolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2011.01.002_bb0005","first-page":"1033","article-title":"My\u00e9lite subaigu\u00eb compliqu\u00e9e de n\u00e9vrite optique","volume":"8","author":"Devic","year":"1894","journal-title":"Bull Med (Paris)"},{"key":"10.1016\/j.jns.2011.01.002_bb0010","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/brain\/50.3-4.687","article-title":"A case of diffuse myelitis associated with optic neuritis","volume":"50","author":"Beck","year":"1927","journal-title":"Brain"},{"key":"10.1016\/j.jns.2011.01.002_bb0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ana.410340211","article-title":"Devic's neuromyelitis optica: a clinicopathological study of 8 patients","volume":"34","author":"Mandler","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/archopht.1949.00900050298007","article-title":"Neuromyelitis optica (Devic's disease): presentation of five cases with pathological study and review of the literature","volume":"42","author":"Stansbury","year":"1949","journal-title":"Arch Ohthalmol"},{"key":"10.1016\/j.jns.2011.01.002_bb0025","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jns.2011.01.002_bb0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00312484","article-title":"Chronic pernicious course in multiple sclerosis with involvement of the optic nerves and total spinal sclerosis (diffuse spinal sclerosis)","volume":"212","author":"Frank","year":"1976","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0035","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/BF02333670","volume":"8","author":"Ghezzi","year":"1987","journal-title":"Ital J Neurol Sci"},{"key":"10.1016\/j.jns.2011.01.002_bb0040","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000310494","article-title":"Neuromyelitis optica","volume":"208","author":"Igarashi","year":"1994","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jns.2011.01.002_bb0045","first-page":"263","article-title":"Neuromyelitis optica: two new cases and review of the literature","volume":"5","author":"Whitham","year":"1985","journal-title":"J Clin Neuroophthalmol"},{"key":"10.1016\/j.jns.2011.01.002_bb0050","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ana.410430409","article-title":"Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination","volume":"43","author":"Storch","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0055","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaut.2009.09.013","article-title":"The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes","volume":"34","author":"Sellner","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jns.2011.01.002_bb0060","first-page":"347","article-title":"Prognosis in acute disseminated encephalomyelitis; with a note on neuromyelitis optica","volume":"22","author":"Miller","year":"1953","journal-title":"Q J Med"},{"key":"10.1016\/j.jns.2011.01.002_bb0065","first-page":"722","article-title":"Devic's optic neuromyelitis. 4 cases","volume":"143","author":"Leys","year":"1987","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.jns.2011.01.002_bb0070","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ana.410340211","article-title":"Devic's neuromyelitis optica: a clinicopathological study of 8 patients","volume":"34","author":"Mandler","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0075","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jnnp.60.4.382","article-title":"Clinical, CSF, and MRI findings in Devic's neuromyelitis optica","volume":"60","author":"O'Riordan","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2011.01.002_bb0080","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"22","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0085","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2011.01.002_bb0090","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.neuroscience.2004.06.076","article-title":"Freeze-fracture and immunogold analysis of aquaporin-4 (AQP4) square arrays, with models of AQP4 lattice assembly","volume":"129","author":"Rash","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2011.01.002_bb0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5","article-title":"Immunogold evidence suggests that coupling of K+ siphoning and water transport in rat retinal M\u00fcller cells is mediated by a coenrichment of Kir4.1 and AQP4 in specific membrane domains","volume":"26","author":"Naggelhus","year":"1999","journal-title":"Glia"},{"key":"10.1016\/j.jns.2011.01.002_bb0100","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20081241","article-title":"Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2","volume":"205","author":"Hinson","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jns.2011.01.002_bb0105","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jns.2011.01.002_bb0110","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.surneu.2003.10.047","article-title":"Aquaporins and brain edema","volume":"61","author":"Griesdale","year":"2004","journal-title":"Surg Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jchemneu.2007.01.006","article-title":"Mapping of aggrecan, hyaluronic acid, heparan sulphate proteoglycans and aquaporin 4 in the central nervous system of the mouse","volume":"33","author":"Costa","year":"2007","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.jns.2011.01.002_bb0120","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1212\/01.wnl.0000345066.57745.50","article-title":"NMO-IgG detected in CSF in seronegative neuromyelitis optica","volume":"72","author":"Klawiter","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0125","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1515\/CCLM.2010.127","article-title":"Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders","volume":"48","author":"Jarius","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jns.2011.01.002_bb0130","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre","volume":"130","author":"Takahashi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jns.2011.01.002_bb0135","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1177\/1352458508092811","article-title":"Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica","volume":"14","author":"Weinstock-Guttman","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2011.01.002_bb0140","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/brain\/awn240","article-title":"Antibody to aquaporin-4 in the long-term course of neuromyelitis optica","volume":"131","author":"Jarius","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jns.2011.01.002_bb0145","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1749-6632.2009.04871.x","article-title":"Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica","volume":"1173","author":"Cayrol","year":"2009","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jns.2011.01.002_bb0150","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.4049\/jimmunol.181.8.5730","article-title":"Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment","volume":"181","author":"Vincent","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2011.01.002_bb0155","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1212\/01.wnl.0000183151.19351.82","article-title":"Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica","volume":"65","author":"Misu","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0160","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1212\/01.WNL.0000289761.64862.ce","article-title":"Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica","volume":"69","author":"Hinson","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0165","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.21802","article-title":"Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica","volume":"66","author":"Bennett","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0170","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo","volume":"66","author":"Bradl","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0175","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbrc.2009.06.085","article-title":"Neuromyelitis optica: passive transfer to rats by human immunoglobulin","volume":"386","author":"Kinoshita","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jns.2011.01.002_bb0180","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jns.2011.01.002_bb0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbrc.2010.02.157","article-title":"Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells","volume":"394","author":"Kinoshita","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jns.2011.01.002_bb0190","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neuroscience.2009.08.032","article-title":"Neurological autoimmunity targeting aquaporin-4","volume":"168","author":"Hinson","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2011.01.002_bb0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/archophthalmol.2007.26","article-title":"Clinical course of optic neuritis in patients with relapsing neuromyelitis optica","volume":"126","author":"Papais-Alvarenga","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jns.2011.01.002_bb0200","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0205","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1212\/WNL.48.1.58","article-title":"Recurrent optic neuromyelitis with endocrinopathies: a new syndrome","volume":"48","author":"Vernant","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0210","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1034\/j.1600-0404.2003.02178.x","article-title":"Devic's neuromyelitis optica: study of nine cases","volume":"108","author":"Fardet","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jns.2011.01.002_bb0215","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1191\/1352458505ms1200cr","article-title":"Neuromyelitis optica with hypothalamic involvement","volume":"11","author":"Poppe","year":"2005","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2011.01.002_bb0220","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s00415-006-0329-2","article-title":"Successful treatment of a hypothalamic lesion in neuromyelitis optica by plasma exchange","volume":"254","author":"Watanabe","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0225","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.0b013e3181d31e35","article-title":"Neuromyelitis optica in France: a multicenter study of 125 patients","volume":"74","author":"Collongues","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0230","doi-asserted-by":"crossref","first-page":"S364","DOI":"10.1007\/s10072-004-0342-0","article-title":"Devic's neuromyelitis optica: clinical features and prognostic factors","volume":"25","author":"Bergamaschi","year":"2004","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jns.2011.01.002_bb0235","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/jnnp.2007.143529","article-title":"Relapsing neuromyelitis optica: long term history and clinical predictors of death","volume":"80","author":"Cabre","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2011.01.002_bb0240","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00415-006-0116-0","article-title":"A patient with a benign course of neuromyelitis optica (Devic's syndrome) over 12years: MRI follow up and histological findings","volume":"253","author":"K\u00f6ller","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0245","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1212\/01.WNL.0000148481.80152.BF","article-title":"Activation of humoral immunity and eosinophils in neuromyelitis optica","volume":"63","author":"Correale","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0250","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/brain\/awh453","article-title":"Intrathecal activation of the IL-17\/IL-8 axis in opticospinal multiple sclerosis","volume":"128","author":"Ishizu","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jns.2011.01.002_bb0255","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1007\/s00415-009-5274-4","article-title":"Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis","volume":"256","author":"Uzawa","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0260","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0b013e3181c919ee","article-title":"B-cell activating factor of the TNF family is upregulated in neuromyelitis optica","volume":"74","author":"Okada","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0265","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jnnp.2008.150698","article-title":"Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker","volume":"80","author":"Misu","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2011.01.002_bb0270","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jns.2010.01.009","article-title":"Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status","volume":"291","author":"Matsushita","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2011.01.002_bb0275","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s00330-009-1425-3","article-title":"Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study","volume":"19","author":"Krampla","year":"2009","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jns.2011.01.002_bb0280","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00415-008-0545-z","article-title":"Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study","volume":"255","author":"Nakamura","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0285","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neurad.2008.12.008","article-title":"MRI of the spinal cord in neuromyelitis optica and recurrent longitudinal extensive myelitis","volume":"36","author":"Cassinotto","year":"2009","journal-title":"J Neuroradiol"},{"key":"10.1016\/j.jns.2011.01.002_bb0290","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1212\/WNL.0b013e3181c1deb9","article-title":"Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis","volume":"73","author":"Yanagawa","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0295","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneur.63.7.964","article-title":"Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0300","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1352458506070725","article-title":"Brain magnetic resonance imaging findings in relapsing neuromyelitis optica","volume":"13","author":"Cabrera-G\u00f3mez","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2011.01.002_bb0305","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.21753","article-title":"\u201cCloud-like enhancement\u201d is a magnetic resonance imaging abnormality specific to neuromyelitis optica","volume":"66","author":"Ito","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0310","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/01.wnl.0000343001.36493.ae","article-title":"Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders","volume":"72","author":"Maga\u00f1a","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0315","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1191\/1352458505ms1236cr","article-title":"An autopsied case of neuromyelitis optica with a large cavitary cerebral lesion","volume":"11","author":"Nakamura","year":"2005","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2011.01.002_bb0320","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/1352458508101935","article-title":"Neuromyelitis optica in Brazil: a study on clinical and prognostic factors","volume":"15","author":"Bichuetti","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2011.01.002_bb0325","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1212\/01.wnl.0000223637.65208.7c","article-title":"Grading cervical cord damage in neuromyelitis optica and MS by diffusion tensor MRI","volume":"67","author":"Benedetti","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0330","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/jnnp.73.4.429","article-title":"Optic neuromyelitis syndrome in Brazilian patients","volume":"73","author":"Papais-Alvarenga","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2011.01.002_bb0335","first-page":"247","article-title":"Neuromyelitis optica in the elderly","volume":"11","author":"Barbieri","year":"1989","journal-title":"Acta Neurol (Napoli)"},{"key":"10.1016\/j.jns.2011.01.002_bb0340","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1212\/01.wnl.0000284600.80782.d5","article-title":"Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders","volume":"70","author":"Banwell","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0345","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1212\/01.wnl.0000314832.24682.c6","article-title":"CNS aquaporin-4 autoimmunity in children","volume":"71","author":"McKeon","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0350","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1474-4422(03)00308-9","article-title":"Multiple sclerosis in the Japanese population","volume":"2","author":"Kira","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0355","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1212\/WNL.56.4.507","article-title":"MS and neuromyelitis optica in Martinique (French West Indies)","volume":"56","author":"Cabre","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0360","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-0404.1980.tb03042.x","article-title":"Multiple sclerosis in North-West India","volume":"62","author":"Chopra","year":"1980","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jns.2011.01.002_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2008.12.001","article-title":"Frequency and clinical patterns of multiple sclerosis in Arab countries: a systematic review","volume":"278","author":"Benamer","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2011.01.002_bb0370","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00415-009-5171-x","article-title":"Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution","volume":"256","author":"Bizzoco","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0375","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1212\/WNL.55.2.318","article-title":"Familial neuromyelitis optica (Devic's syndrome) with late onset in Japan","volume":"55","author":"Yamakawa","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0380","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/brain\/122.9.1689","article-title":"HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies","volume":"122","author":"Yamasaki","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.jns.2011.01.002_bb0385","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1399-0039.2008.01172.x","article-title":"Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders","volume":"73","author":"Matsushita","year":"2009","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jns.2011.01.002_bb0390","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1191\/135248506ms1252oa","article-title":"HLA-dPB1*0501 is not uniquely associated with opticospinal multiple sclerosis in Japanese patients. Important role of DPB1*0301","volume":"12","author":"Fukazawa","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2011.01.002_bb0395","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/1352458508102085","article-title":"Is neuromyelitis optica associated with human leukocyte antigen?","volume":"15","author":"Z\u00e9phir","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2011.01.002_bb0400","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.nbd.2009.10.013","article-title":"Common CYP7A1 promoter polymorphism associated with risk of neuromyelitis optica","volume":"37","author":"Kim","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jns.2011.01.002_bb0405","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaut.2009.09.013","article-title":"The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes","volume":"34","author":"Sellner","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jns.2011.01.002_bb0410","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00415-007-0509-8","article-title":"Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients","volume":"254","author":"Saiz","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0415","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2796.2007.01794.x","article-title":"Neuromyelitis optica following CMV primo-infection","volume":"261","author":"Tran","year":"2007","journal-title":"J Intern Med"},{"key":"10.1016\/j.jns.2011.01.002_bb0420","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s00415-008-0870-2","article-title":"Mycoplasma pneumonia as a cause of neuromyelitis optica?","volume":"255","author":"Gebhardt","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0425","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/1352458507082355","article-title":"Neuromyelitis optica (Devic's disease) in a patient with syphilis","volume":"14","author":"Wilcox","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2011.01.002_bb0430","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jns.2011.01.002_bb0435","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1212\/01.wnl.0000256822.01222.bd","article-title":"NMO-IgG in the diagnosis of neuromyelitis optica","volume":"68","author":"Jarius","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0440","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1371\/journal.pmed.0040133","article-title":"Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica","volume":"4","author":"Paul","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.jns.2011.01.002_bb0445","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/1352458507084595","article-title":"NMO-IgG and Devic's neuromyelitis optica: a French experience","volume":"14","author":"Marignier","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2011.01.002_bb0450","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jneuroim.2008.03.009","article-title":"Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay","volume":"196","author":"Hayakawa","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2011.01.002_bb0455","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.65.7.913","article-title":"Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis","volume":"65","author":"Waters","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0460","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1468-1331.2008.02376.x","article-title":"Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese","volume":"16","author":"Chan","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0465","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1590\/S0004-282X2008000300001","article-title":"Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica","volume":"66","author":"Adoni","year":"2008","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.jns.2011.01.002_bb0470","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1352458509106851","article-title":"Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients","volume":"15","author":"Fazio","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2011.01.002_bb0475","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2010.01.002","article-title":"Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen","volume":"291","author":"Jarius","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2011.01.002_bb0480","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jneuroim.2009.10.002","article-title":"Western blot analysis for the detection of serum antibodies recognizing linear Aquaporin-4 epitopes in patients with neuromyelitis optica","volume":"217","author":"Marnetto","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2011.01.002_bb0485","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/archneurol.2009.178","article-title":"Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays","volume":"66","author":"McKeon","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0490","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1001\/archneur.63.10.1398","article-title":"Neuromyelitis optica IgG status in acute partial transverse myelitis","volume":"63","author":"Scott","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0495","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/08820530802049921","article-title":"Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations","volume":"23","author":"Hamnik","year":"2008","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.jns.2011.01.002_bb0500","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","article-title":"NMO-IgG predicts the outcome of recurrent optic neuritis","volume":"70","author":"Matiello","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0505","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/jnnp.2008.146894","article-title":"Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis","volume":"81","author":"Petzold","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2011.01.002_bb0510","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.20770","article-title":"Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis","volume":"59","author":"Weinshenker","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0515","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1179\/016164106X98279","article-title":"Progressive necrotizing myelopathy: part of the spectrum of neuromyelitis optica?","volume":"28","author":"Okai","year":"2006","journal-title":"Neurol Res"},{"key":"10.1016\/j.jns.2011.01.002_bb0520","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0022-510X(74)90224-X","article-title":"Clinical studies of multiple sclerosis in Japan: classical multiple sclerosis and Devic's disease","volume":"23","author":"Shibasaki","year":"1974","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2011.01.002_bb0525","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1474-4422(03)00308-9","article-title":"Multiple sclerosis in the Japanese population","volume":"2","author":"Kira","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0530","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/jnnp.2006.114165","article-title":"Anti-aquaporin 4 antibody in Japanese multiple sclerosis: the presence of optic spinal multiple sclerosis without long spinal cord lesions and anti-aquaporin 4 antibody","volume":"78","author":"Tanaka","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2011.01.002_bb0535","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0540","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00415-006-0400-z","article-title":"Two subtypes of optic-spinal form of multiple sclerosis in Japan: clinical and laboratory features","volume":"254","author":"Nakashima","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0545","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/brain\/awm027","article-title":"Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese","volume":"130","author":"Matsuoka","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jns.2011.01.002_bb0550","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non organ-specific autoimmunity","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0555","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1352458509353651","article-title":"Recurrent neuromyelitis optica in Brazilian patients: clinical, immunological, and neuroimaging characteristics","volume":"16","author":"Adoni","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2011.01.002_bb0560","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/mus.21197","article-title":"Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica","volume":"39","author":"McKeon","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2011.01.002_bb0565","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/archneur.65.5.629","article-title":"Aquaporin-4 autoantibodies in a paraneoplastic context","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0570","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1468-1331.2008.02376.x","article-title":"Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese","volume":"16","author":"Chan","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0575","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/1352458508100837","article-title":"Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder","volume":"15","author":"Bonnan","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2011.01.002_bb0580","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1212\/WNL.0b013e3181a82621","article-title":"A case of NMO seropositive for aquaporin-4 antibody more than 10years before onset","volume":"72","author":"Nishiyama","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0585","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1212\/WNL.58.1.143","article-title":"Plasma exchange for severe attacks of CNS demyelination: predictors of response","volume":"58","author":"Keegan","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0590","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/WNL.0b013e3181b879be","article-title":"Plasma exchange for acute attacks of CNS demyelination: predictors of improvement at 6months","volume":"73","author":"Llufriu","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0595","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.51.4.1219","article-title":"Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine","volume":"51","author":"Mandler","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0600","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11940-005-0010-6","article-title":"Neuromyelitis optica","volume":"7","author":"Wingerchuk","year":"2005","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0605","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","article-title":"An open label study of the effects of rituximab in neuromyelitis optica","volume":"64","author":"Cree","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.01.002_bb0610","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/archneur.65.11.noc80069","article-title":"Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients","volume":"65","author":"Jacob","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0615","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10072-007-0823-z","article-title":"Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease)","volume":"28","author":"Capobianco","year":"2007","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jns.2011.01.002_bb0620","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neurol.2007.10.009","article-title":"Failure of rituximab in relapsing neuromyelitis optica: case report with two-year prospective follow-up","volume":"164","author":"Cassinotto","year":"2008","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.jns.2011.01.002_bb0625","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/rheumatology\/kei263","article-title":"Sustained improvement of a girl affected with Devic's disease over 2years of mycophenolate mofetil treatment","volume":"45","author":"Falcini","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jns.2011.01.002_bb0630","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archneurol.2009.175","article-title":"Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients","volume":"66","author":"Jacob","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0635","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2169\/internalmedicine.46.0217","article-title":"Intermittent intravenous immunoglobulin successfully prevents relapses of neuromyelitis optica","volume":"46","author":"Okada","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.jns.2011.01.002_bb0640","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1468-1331.2007.01807.x","article-title":"Relapsing neuromyelitis optica responsive to glatiramer acetate treatment","volume":"14","author":"Gartzen","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0645","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archneur.63.7.957","article-title":"Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease)","volume":"63","author":"Weinstock-Guttman","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2011.01.002_bb0650","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/1352458506070732","article-title":"Immunosuppressive therapy is more effective than interferon in neuromyelitis optica","volume":"13","author":"Papeix","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2011.01.002_bb0655","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00415-007-0730-5","article-title":"Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis","volume":"255","author":"Shimizu","year":"2008","journal-title":"J Neurol"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X11000049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X11000049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T07:32:32Z","timestamp":1559979152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X11000049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":131,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0022510X11000049"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2011.01.002","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}